Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease

被引：16
|
作者：
Marion, JF [1 ]
机构：
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA
来源：
INFLAMMATORY BOWEL DISEASES | 1998年 / 4卷 / 02期
关键词：
adverse reactions; azathioprine; Crohn's disease; drug use in pregnancy; 6-mercaptopurine; pediatric; ulcerative colitis;
D O I：
10.1097/00054725-199805000-00016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [1] The Efficacy of Low Dose Azathioprine/6-mercaptopurine in Patients with Inflammatory Bowel Disease
    Kim, Dong Uk
    Kim, Young-Ho
    Kim, Beom Jin
    Chang, Dong Kyung
    Son, Hee Jung
    Rhee, Poong-Lyul
    Kim, Jae J.
    Rhee, Jong Chul
    HEPATO-GASTROENTEROLOGY, 2009, 56 (94-95) : 1395 - 1402
  • [2] Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease
    Ramakrishna, J
    Langhans, N
    Calenda, K
    Grand, RJ
    Verhave, M
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1996, 22 (03) : 296 - 302
  • [3] Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease
    Ananthakrishnan, Ashwin N.
    Attila, Tan
    Otterson, Mary F.
    Lipchik, Randolph J.
    Massey, Benson T.
    Komorowski, Richard A.
    Binion, David G.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (07) : 682 - 688
  • [4] 6-Mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine
    Domènech, E
    Nos, P
    Papo, M
    López-San Roman, A
    Garcia-Planella, E
    Gassull, MA
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (01) : 52 - 55
  • [5] Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?
    Su, CG
    Stein, RB
    Lewis, JD
    Lichtenstein, GR
    DIGESTIVE AND LIVER DISEASE, 2000, 32 (06) : 518 - 531
  • [6] Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease
    Mottet, Christian
    Schoepfer, Alain M.
    Juillerat, Pascal
    Cosnes, Jacques
    Froehlich, Florian
    Kessler-Brondolo, Vera
    Seibold, Frank
    Rogler, Gerhard
    Vavricka, Stephan R.
    Michetti, Pierre
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (11) : 2733 - 2747
  • [7] Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
    Gisbert, JP
    Luma, M
    Maté, J
    González-Guijarro, L
    Cara, C
    Pajares, JM
    MEDICINA CLINICA, 2003, 121 (01): : 1 - 5
  • [8] Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease
    Leung, Yvette
    Sparrow, Miles P.
    Schwartz, Marc
    Hanauer, Stephen B.
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (03) : 162 - 167
  • [9] Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease
    Bradford, Kara
    Shih, David Q.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (37) : 4166 - 4173
  • [10] Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naive to thiopurine treatment
    Alaish, Ram
    Lundgren, David
    Suhr, Ole B.
    Werner, Marten
    Karling, Pontus
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (07) : 594 - 600
12345